CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $304,997 | -28.7% | 7,503 | +14.5% | 0.00% | -42.9% |
| Q3 2022 | $428,000 | +9.5% | 6,551 | +1.8% | 0.01% | +16.7% |
| Q2 2022 | $391,000 | +13.7% | 6,434 | +19.7% | 0.01% | +20.0% |
| Q1 2022 | $344,000 | -1.1% | 5,377 | +16.9% | 0.01% | 0.0% |
| Q4 2021 | $348,000 | -29.6% | 4,598 | +4.0% | 0.01% | -37.5% |
| Q3 2021 | $494,000 | -20.3% | 4,420 | +15.6% | 0.01% | -27.3% |
| Q2 2021 | $620,000 | +138.5% | 3,823 | +78.7% | 0.01% | +83.3% |
| Q1 2021 | $260,000 | – | 2,139 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |